uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Gains from Investment Securities (2023 - 2026)

uniQure (QURE) posted Gains from Investment Securities of -$16.0 million for Q2 2026, down 323.72% on a QoQ basis from -$3.8 million in Q1 2026, and down 808.52% year-over-year from $2.3 million in Q2 2025.

Analysis

uniQure (QURE) Gains from Investment Securities (2023 - 2026) Analysis & Trends

uniQure has reported Gains from Investment Securities for 4 years, with the latest figure at -$16.0 million in Q2 2026.

  • On a quarterly basis, Gains from Investment Securities fell 808.52% year-over-year to -$16.0 million in Q2 2026; TTM through Jun 2026 was -$32.2 million, a 1082.47% decrease from a year earlier, with the FY2025 full-year figure at -$12.4 million, down 582.72% from the prior year.
  • Gains from Investment Securities was -$16.0 million for Q2 2026 at uniQure, down from -$3.8 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $14.2 million in Q3 2023, with the low at -$18.1 million in Q4 2025.
  • Average Gains from Investment Securities over 4 years is -$1.0 million, with a median of $226000.0 recorded in 2023.
  • The largest YoY upside for Gains from Investment Securities was 1486.86% in 2025 against a maximum downside of 8531.16% in 2025.
  • Over 4 years, Gains from Investment Securities stood at $454000.0 in 2023, then plunged by 52.64% to $215000.0 in 2024, then sank by 8531.16% to -$18.1 million in 2025, then climbed by 11.9% to -$16.0 million in 2026.
  • The last three Gains from Investment Securities figures came in at -$16.0 million (Q2 2026), -$3.8 million (Q1 2026), and -$18.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.97 Mn
Mar 31, 2026 -3.77 Mn
Dec 31, 2025 -18.13 Mn
Sep 30, 2025 5.70 Mn
Jun 30, 2025 2.25 Mn
Mar 31, 2025 1.22 Mn
Dec 31, 2024 215,000.00
Sep 30, 2024 -411,000.00
Jun 30, 2024 -1.79 Mn
Mar 31, 2024 165,000.00
Dec 31, 2023 454,000.00
Sep 30, 2023 14.23 Mn
Jun 30, 2023 237,000.00
Mar 31, 2023 975,000.00
API Access

uniQure Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=QURE&period=max&api_key=YOUR_API_KEY